DE3767629D1 - Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung. - Google Patents

Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Info

Publication number
DE3767629D1
DE3767629D1 DE8787113774T DE3767629T DE3767629D1 DE 3767629 D1 DE3767629 D1 DE 3767629D1 DE 8787113774 T DE8787113774 T DE 8787113774T DE 3767629 T DE3767629 T DE 3767629T DE 3767629 D1 DE3767629 D1 DE 3767629D1
Authority
DE
Germany
Prior art keywords
cell differentiation
differentiation factor
human
production
dnas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787113774T
Other languages
English (en)
Inventor
Tasuku Honjo
Kiyoshi Takatu
Eva Severinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3767629D1 publication Critical patent/DE3767629D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5409—IL-5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8787113774T 1986-09-20 1987-09-21 Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung. Expired - Lifetime DE3767629D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22328486 1986-09-20

Publications (1)

Publication Number Publication Date
DE3767629D1 true DE3767629D1 (de) 1991-02-28

Family

ID=16795717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787113774T Expired - Lifetime DE3767629D1 (de) 1986-09-20 1987-09-21 Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Country Status (8)

Country Link
US (2) US5324640A (de)
EP (1) EP0261625B1 (de)
JP (1) JP2642103B2 (de)
AT (1) ATE60359T1 (de)
AU (1) AU604055B2 (de)
CA (1) CA1340689C (de)
DE (1) DE3767629D1 (de)
ES (1) ES2039390T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor
US5324640A (en) * 1986-09-20 1994-06-28 Suntory Limited Human B-cell differentiation factor and process of producing said factor
EP0267779A3 (de) * 1986-11-10 1990-01-17 Schering Biotech Corporation Menschlicher pleitroper Immunfaktor und dessen Muteine
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
EP0557420A1 (de) * 1990-11-16 1993-09-01 Schering Corporation Methode um die differenzierung von myeloblasten mit interleukin-5 zu induzieren
JPH0775593A (ja) * 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256042A1 (de) * 1986-01-15 1988-02-24 AMERSHAM INTERNATIONAL plc Interleukin
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor
US5324640A (en) * 1986-09-20 1994-06-28 Suntory Limited Human B-cell differentiation factor and process of producing said factor
JPS63146798A (ja) * 1986-11-10 1988-06-18 シェリング・バイオテック・コーポレーション ヒト多機能性免疫因子及びその突然変異タンパク
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
AU604055B2 (en) 1990-12-06
EP0261625A2 (de) 1988-03-30
ES2039390T3 (es) 1993-10-01
CA1340689C (en) 1999-08-03
JPS63185387A (ja) 1988-07-30
EP0261625B1 (de) 1991-01-23
ATE60359T1 (de) 1991-02-15
AU7880987A (en) 1988-05-19
US5324640A (en) 1994-06-28
JP2642103B2 (ja) 1997-08-20
US5530098A (en) 1996-06-25
EP0261625A3 (en) 1988-10-26

Similar Documents

Publication Publication Date Title
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
DE69636728D1 (de) Neues protein und verfahren zu dessen herstellung
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
IL87025A0 (en) Recombinant fibroblast growth factor analogs,their production,dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE26463T1 (de) Verfahren zur herstellung von menschlichem leukozyten-interferon.
ES8603574A1 (es) "procedimiento de tecnologia genetica para preparar secuen- cias parciales del gamma-interferon de humano".
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
PL274669A1 (en) Method of obtaining a gene able to code authentical human serum albumin
ES2090018T3 (es) Clon de adn de trombomodulina humana.
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
ATE124454T1 (de) Gentechnische herstellung von faktor xiiia.
DE3767629D1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
WO1995030001A3 (en) Novel p-selectin ligand protein
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
DE69530647D1 (de) Für biosynthetische Insulinvorstufen kodierende DNA-Sequenzen und Verfahren zur Herstellung von Insulin
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
ES2115208T3 (es) Proteina de la superficie celular de brevibacterium lactofermentum.
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
DE148922T1 (de) Hybride dns-synthese des epidermwachstumsfaktors.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition